<Suppliers Price>

Epimedokoreanin B

Names

[ CAS No. ]:
161068-53-7

[ Name ]:
Epimedokoreanin B

[Synonym ]:
2-(3,4-Dihydroxy-5-((E)-3-methyl-but-2-enyl)-phenyl)-5,7-dihydroxy-8-(3-methyl-but-2-enyl)-1-benzopyran-4-one
2-[3,4-Dihydroxy-5-(3-methyl-2-buten-1-yl)phenyl]-5,7-dihydroxy-8-(3-methyl-2-buten-1-yl)-4H-chromen-4-one
2-[3,4-Dihydroxy-5-((E)-3-methyl-but-2-enyl)-phenyl]-5,7-dihydroxy-8-(3-methyl-but-2-enyl)-1-benzopyran-4-one
4H-1-Benzopyran-4-one, 2-[3,4-dihydroxy-5-(3-methyl-2-buten-1-yl)phenyl]-5,7-dihydroxy-8-(3-methyl-2-buten-1-yl)-

Biological Activity

[Description]:

Epimedokoreanin B is a natural flavonoid with anticancer, anti-inflammatory and antibacterial effects. Epimedokoreanin B inhibits the growth of lung cancer cells through endoplasmic reticulum stress-mediated Apoptosis accompanied by autophagosome accumulation. Epimedokoreanin B is an anti-periodontitis agent that inhibits gingipains and Porphyromonas gingivalis growth and biofilm formation[1][2][3].

[Related Catalog]:

Signaling Pathways >> Apoptosis >> Apoptosis
Research Areas >> Cancer
Research Areas >> Infection
Research Areas >> Inflammation/Immunology
Signaling Pathways >> Anti-infection >> Bacterial

[In Vitro]

Epimedokoreanin B (compound6; 3.13-25 μM; 48 hours) 对肺癌细胞 A549、Calu1 和 H1299 的增殖显示出显着的抑制作用。Epimedokoreanin B 对人支气管上皮细胞 BEAS-2B 无毒性[1]。 Epimedokoreanin B 处理抑制 A549 和 NCI-H292 细胞中伴随细胞质空泡形成的细胞增殖和迁移。Epimedokoreanin B 处理的细胞中观察到自噬体聚集并伴有自噬通量阻断,这与内质网应激的发生相符[2]。 Epimedokoreanin B(5 μM;24 小时)抑制 CD163 表达和 IL-10 的产生,这是已知的 M2 标记,表明 Epimedokoreanin B 抑制人单核细胞衍生巨噬细胞 (HMDM) 中的 M2 极化。Epimedokoreanin B 抑制 HMDMs 中的 STAT3 激活[4]。 Cell Cytotoxicity Assay[1] Cell Line: A549, Calu1 and H1299 cells Concentration: 3.13 μM, 6.25 μM, 12.5 μM and 25.0 μM Incubation Time: 48 hours Result: Showed significate inhibitory effect on proliferation against lung cancer cell A549, Calu1 and H1299. Western Blot Analysis[4] Cell Line: Human monocyte-derived macrophages (HMDMs) Concentration: 5 μM Incubation Time: 24 hours Result: Significantly suppressed IL-10-induced JAK1/STAT3 activation.and H1299.

[In Vivo]

Epimedokoreanin B(20 mg/kg;口服;每周三次;持续 17 天)抑制 LM8 荷瘤鼠模型中的肿瘤生长[4]。 Animal Model: Female C3H mice (8-10 weeks old) injected with LM8 cells[4] Dosage: 20 mg/kg Administration: Oral administration; thrice a week; for 17 days Result: Inhibited tumor growth.

[References]

[1]. Huaran Zhang, et al. Flavonoids from the leaves of Epimedium Koreanum Nakai and their potential cytotoxic activities. Nat Prod Res. 2020 May;34(9):1256-1263.  

[2]. Hao Zheng, et al. Epimedokoreanin B inhibits the growth of lung cancer cells through endoplasmic reticulum stress-mediated paraptosis accompanied by autophagosome accumulation. Chem Biol Interact. 2022 Oct 1;366:110125.  

[3]. T Kariu, et al. Inhibition of gingipains and Porphyromonas gingivalis growth and biofilm formation by prenyl flavonoids. J Periodontal Res. 2017 Feb;52(1):89-96.  

[4]. Cheng Pan , et al. Flavonoid Compounds Contained in Epimedii Herba Inhibit Tumor Progression by Suppressing STAT3 Activation in the Tumor Microenvironment. Front Pharmacol. 2020 Mar 18;11:262.  

Chemical & Physical Properties

[ Density]:
1.3±0.1 g/cm3

[ Boiling Point ]:
665.9±55.0 °C at 760 mmHg

[ Molecular Formula ]:
C25H26O6

[ Molecular Weight ]:
422.470

[ Flash Point ]:
228.2±25.0 °C

[ Exact Mass ]:
422.172943

[ PSA ]:
111.13000

[ LogP ]:
6.59

[ Vapour Pressure ]:
0.0±2.1 mmHg at 25°C

[ Index of Refraction ]:
1.650


Related Compounds

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.